[
    [
        {
            "time": "2018-01-02",
            "original_text": "Could 2018's Best-Performing Big Pharma Stock So Far Go Even Higher Soon?",
            "features": {
                "keywords": [
                    "Best-Performing",
                    "Big Pharma",
                    "Higher",
                    "Soon"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Could 2018's Best-Performing Big Pharma Stock So Far Go Even Higher Soon?",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-03",
            "original_text": "J&J Submits NDA to the FDA for Depression Drug in Adults",
            "features": {
                "keywords": [
                    "J&J",
                    "NDA",
                    "FDA",
                    "Depression Drug"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "J&J Submits NDA to the FDA for Depression Drug in Adults",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-04",
            "original_text": "Lilly Announces Positive Phase 3 Results in Study of Flortaucipir PET Imaging Agent",
            "features": {
                "keywords": [
                    "Lilly",
                    "Positive Phase 3",
                    "Flortaucipir",
                    "PET Imaging"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly Announces Positive Phase 3 Results in Study of Flortaucipir PET Imaging Agent",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "Eli Lilly Has Trimmed Its Stake in Biopharma Firm Zymeworks",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Trimmed Stake",
                    "Zymeworks"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly Has Trimmed Its Stake in Biopharma Firm Zymeworks",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-06",
            "original_text": "Endo (ENDP) Hits 52-Week High, Can the Run Continue?",
            "features": {
                "keywords": [
                    "Endo",
                    "52-Week High",
                    "Run Continue"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Endo (ENDP) Hits 52-Week High, Can the Run Continue?",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-07",
            "original_text": "Invesco Dynamic Pharmaceuticals ETF Experiences Big Inflow",
            "features": {
                "keywords": [
                    "Invesco",
                    "Pharmaceuticals ETF",
                    "Big Inflow"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Invesco Dynamic Pharmaceuticals ETF Experiences Big Inflow",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-08",
            "original_text": "3 Big Stock Charts for Wednesday: FMC, Eli Lilly and Hewlett Packard Enterprise",
            "features": {
                "keywords": [
                    "Stock Charts",
                    "FMC",
                    "Eli Lilly",
                    "Hewlett Packard Enterprise"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "technology"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3 Big Stock Charts for Wednesday: FMC, Eli Lilly and Hewlett Packard Enterprise",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-09",
            "original_text": "Boost for 'made in China' medicine as Chi-Med wins key approval",
            "features": {
                "keywords": [
                    "made in China",
                    "Chi-Med",
                    "key approval"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Boost for 'made in China' medicine as Chi-Med wins key approval",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-10",
            "original_text": "BCRX At Its Zenith, CRON Walks The Walk, TSRO To Report Data In Nov.",
            "features": {
                "keywords": [
                    "BCRX",
                    "CRON",
                    "TSRO",
                    "Report Data"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "BCRX At Its Zenith, CRON Walks The Walk, TSRO To Report Data In Nov.",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]